Access to publications

Access to publications

Access to publications

  1. New Genetic Variants Increase Susceptibility to Hepatocellular Carcinoma in Hepatitis C Virus‐Infected Patients (2019)
    Majdi Nagara, Brice Masi, Nicolas Duflot, Rodrigo Felierano Do Carmo, Helia Dessein, Patricia Moura, Sandrine Cabantous, Luydson Silva Vasconcelos, Leila Beltrao, Vinciane Marquet, Audrey Romano, Jean Hardwigsen and Alain Dessein, Bilhigenetics, Instituto Do Fegado, Inserm, MD, Hôpital De La Timone

    HEPATHOLOGY, october, 2019, VOLUME 70, NUMBER1 (SUPPL) - AASLD Posters n°2093
    https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.30941

  2. Multifaceted population structure and reproductive strategy in Leishmanio donovani Complexe in one Sudanese Village (2011)
    ROUGERON V, DE MEEUS T, HIDE M, LE FALHER G, BUCHETON B, DEREURE J, EL-SAFI SH, DESSEIN A, BANULS AL

    PLOSNeglected Tropical Diseases, 5(12)1448:1-11

  3. Variants of CTGF are associated with hepatic fibrosis in Chinese, Sudanese and Brazilians infected with Schistosomes (2009)
    DESSEIN A, CHEVILLARD C, ARNAUD V, HOU X, HAMDOUM AA, DESSEIN H, HE H, ABDELMABOUD SA, LUO X, LI J, VAROQUAUX A, MERGHANI A, ABDELWAHED M, ZHOU J, MONIS A, PITTA MG, GASMELSEED N, CABANTOUS S, ZHAO Y, PRATA A, BRANDT C, ELWALI NE, ARGIRO L, LI Y

    Journal of Experimental Medicine,October 26,206(11):2321-8 IF=15.4

  4. Genetic evidence for the aggravation of Plasmodium falciparum Malaria by Interleukin 4 (2009)
    CABANTOUS S, POUDIOUGOU B, OUMAR AA, TRAORE A, BARRY A, VITTE J, BONGRAND P, MARQUET S, DOUMBO O and DESSEIN AJ

    Journal of Infectious Diseases, November 15:200(10):1530-9 IF=5.7

  5. IL-17 and IL-22 are associated with protection against human Kala Azar caused by Leishmania donovani (2009)
    PITTA MG, ROMANO A, CABANTOUS S, HENRI S, HAMMAD A, KOURIBA B, ARGIRO L, EL KHEIR M, BUCHETON B, MARY C, EL SAFI SH, DESSEIN A

    Journal of Clinical Investigation, August 119(8):2379-87 IF=16.5

  6. Regulatory role of interleukin-10 and interferon-gamma in severe hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum (2008)
    ARNAUD V, LI J, WANG Y, FU X, MENGZHI S,LUO X, HOU X, DESSEIN H, JIE Z, XIN-LING Y, HE H, McMANUS DP, LI Y, DESSEIN A

    Journal of Infectious Diseases, Aug 1 ; 198(3) :418-426 IF=5.7

  7. A functional promoter variant in IL12B predisposes to cerebral malaria (2008)
    MARQUET S, DOUMBO O, CABANTOUS S, POUDIOUGOU B, ARGIRO L, SAFEUKUI I, KONATE S, SISSOKO S, CHEVEREAU E, TRAORE A, KEITA MM, CHEVILLARD C, ABEL L, DESSEIN AJ

    Human Molecular Genetics, July 15:17(14):2190-2195 IF=7

  8. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions caused by Leishmania braziliensis (2008)
    SALHI A, RODRIGUES V Jr, SANTORO F, DESSEIN H, ROMANO A, CASTELLANO LR, SERTORIO M, RAFATI S, CHEVILLARD C, PRATA A, ALCAIS A, ARGIRO L, DESSEIN A

    The Journal of Immunology, May 1;180(9):6139-6148 IF=6.2

  9. Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis (2007)
    BUCHETON B, ARGIRO L, CHEVILLARD C, MARQUET S, KHEIR MM, MERGANI A, EL SAFI SH, DESSEIN AJ

    Genes Immun, Jan 8(1):79-83 IF= 4

  10. Mendelian and complex genetics of susceptibility and resistance to parasitic infections (2006)
    CAMPINO S, KWIATKOWSKI D and DESSEIN A

    Seminars in Immunology, Dec 18(6):411-422 IF=9.1

  11. Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL13-591A/G polymorphisms and Schistosoma haematobium infections (2005)
    KOURIBA B, CHEVILLARD C, BREAM JH, ARGIRO, DESSEIN H, ARNAUD V, SANGARE L, DABO A, BEAVOGUI AH, ARAMA C, TRAORE HA, DOUMBO O and DESSEIN A

    Journal of Immunology, 15:174(10),6274-6281 IF=6.2

  12. Evidence that Interferon-gamma plays a protective role during cerebral malaria (2005)
    CABANTOUS S,POUDIOUGOU B, TRAORE A, KEITA M, CISSE MB, DOUMBO O, DESSEIN AJ, MARQUET S

    Journal of Infectious Diseases, Sep 1;192(5):854-60 IF=5.7

  13. Familial aggregation of cerebral malaria and severe malarial anemia (2005)
    RANQUE S, SAFEUKUI-NOUBISSI I, POUDIOUGOU B, TRAORE A, KEITA M, TRAORE D, DIAKITE M, CISSE MB, KEITA M, DOUMBO OK, DESSEIN AJ

    Journal of Infectious Diseases, Mar 1;191(5):799-804 (IF=5,7)

  14. Leishmaniasis (2004)
    DESJEUX P and MS. The TDR reference group on leishmaniasis (BOELAERT, S, CROFT, S, STUART K, TIBAYRENC M, MCMAHO PRATT, D, MAROLI M, REED S, DESSEIN A, BLACKWELL J, ALVAR J, DAVIES C, SARAVIA N, MENNE B, ELHASSAN AM)

    Nat. Rev. Microbiol., 2(9):692

  15. Genetics of human susceptibility to infection and hepatic diseases caused by schistosomes (2004)
    DESSEIN AJ, EL WALI N, MARQUET S, ABEL L, RODRIGUES V, EBOUMBOU MOUKOKO C, DESSEIN H, ARGIRO L, HENRI S, HILLAIRE D, GACHUHI K, PRATA A, MAGZOUB M, CHEVILLARD C

    Advances in Molecular and Cellular Microbiology, “Susceptibility to infectious Diseases, edited by Bellamy”, 337-361

  16. Vanin-1 -/-mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores (2004)
    MARTIN F, PENET MF, MALERGUE F, LEPIDI H, DESSEIN A, GALLAND F, DE REGGI M, NAQUET P and GHARIB B

    Journal of Clinical Investigation,113:4, 591-597. (IF:12)

  17. A major susceptibility locus on chromosome 22q12 plays a critical role in outbreak of visceral leishmaniasis (2003)
    BUCHETON B, ABEL L, EL SAFI S, KHEIR MM, PAVEK S, LEMAINQUE A and DESSEIN AJ

    American Journal of Human Genetics, 73:1052-1060. (IF:11)

  18. Interferon gamma polymorphisms (IFN-gamma) +2109 and (IFN-gamma) +3810 are associated with severe hepatic fibrosis in human schistosomiasis (Schistosoma Mansoni) (2003)
    CHEVILLARD C, EBOUMBOU MC, ELWALI NE, BREAM JH, KOURIBA B, ARGIRO L, RAHOUD S, MERGANI A, HENRI S, GAUDART J, MOHAMED-ALI Q, YOUNG HA, DESSEIN AJ

    Journal of Immunology, 171:5596-5601. (IF:7.1)

  19. Severe hepatic fibrosis in Schistosoma Mansoni infection is controled by a major locus that is closely linked to the Interferon Gamma Receptor gene (1999)
    DESSEIN AJ, HILLAIRE D, ALWALI NE, MARQUET S, QURASHI MA, MIRGHANI A, HENRI S, ABDELHAMEED AA, SAEED OK, MAGZOUB MMA, ABEL L

    Am. J. Hum. Genet.,65:709-721. (IF:11)

  20. Genetic epidemiology of infectious diseases in humans with special reference to human design of population based studies (1998)
    ABEL L and DESSEIN AJ

    Emerg. Infect. Dis., 4(4), 593-603. (IF:6)

  21. High prevalence of GB-C/hepatitis G virus in a Brazilian population with helminth infection (1998)
    GALLIAN P, RODRIGUES V, CANTALOUBE JF, DESSEIN H, De MICCO P, DESSEIN AJ and De LAMBALLERIE X

    J. Med. Virol.,56, 310-315. (IF:4)

  22. Linkage analysis of blood Plasmodium falciparumlevels : interest of the 5q31-q33 region (1998)
    GARCIA A, MARQUET S, BUCHETON B, HILLAIRE D, COT M, FIEVET N, DESSEIN A, ABEL L

    Am. J. Trop. Med. Hyg.,58(6), 705-709. (IF :2.1)

  23. The impact of host genetics on susceptibility to human infectious diseases (1997)
    ABEL L and DESSEIN AJ

    Opin. Immunol., 9(4), 509-516. (IF :13.7)

  24. Characterization of a schistosome T cell-stimulating antigen (SM10) associated with protective immunity in humans (1997)
    KOHLSTADT, S., COUISSINIER-PARIS, P., BOURGOIS A., BOUCHON, B., PIPER K., KOLBE, H. and DESSEIN, A.

    Mol. Biochem. Parasitol.,84, 155-165. (IF:2.4)

  25. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansonion chromosome 5q31-q33 (1996)
    MARQUET, S., ABEL, L., HILLAIRE, D., DESSEIN, H., KALIL, J., FEINGOLD, J., WEISSENBACH, J. AND DESSEIN, A.J.

    Nat. Genet.,14(2), 181-184. (IF:30)

  26. Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected withSchistosoma mansoni (1996)
    RODRIGUES, V. Jr, ABEL L., PIPER K., and DESSEIN A.J.

    Am. J. Hum. Genet., 59(2), 453-461. (IF:11)

  27. Schistosoma-specific helper T-cell clones from subjects resistant to infection by Schistosoma mansoniare Th0/2 (1995)
    COUISSINIER-PARIS, P. and DESSEIN, A.J.

    Eur. J. Immunol.,25(8), 2295-2302. (IF:5)

  28. Identification of a major T-cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni (1995)
    COUISSINIER-PARIS, P., BOURGOIS, A., DESSEIN, H., BACELLAR, O., RODRIGUES, KOHLSTADT, S., BUONAVISTA, N., PENE, J. and DESSEIN, A.J.

    Eur. J. Immunol.,25(4), 903-910. (IF :5)

  29. Resistance to Schistosoma mansoni in humans : influence of the IgE/IgG4 and IgG2 in immunity to reinfection after chemotherapy (1993)
    DEMEURE, C., RIHET, P., ABEL, L., OUATTARA, M., BOURGOIS, A. and DESSEIN, A.J.

    J. Inf. Dis. 168(4), 1000-1008. (IF:4.9)

  30. Strong serum inhibition of specific IgE correlated to competing IgG4 revealed by a new methodology in subjects from a S. mansoniendemic area (1992)
    RIHET, P., DEMEURE, C.E., DESSEIN, A.J.and BOURGOIS, A.

    Eur. J. Immunol., 22(8), 2063-2070. (IF:5)

  31. Evidence for genetic factors for resistance/susceptibility to schistosome infection (1992)
    ABEL,L. and DESSEIN, A.J.

    Am. J. Hum. Gen.,51, 206-209. (Letter). (IF:11)

  32. Evidence for the segregation of a major gene in human susceptibility / resistance to infection by Schistosoma mansoni (1991)
    ABEL, L., DEMENAIS, F.P., PRATA, A., and DESSEIN, A.J.

    Am. J. Human Gen., 48(5), 959-970. (IF:11)

  33. The major parasite surface antigen associated with human resistance to schistosomiasis is a 37 kDa glyceraldehyde-3P-dehydrogenase (1989)
    GOUDOT-CROZEL, V., CAILLOL, D., DJABALI, M., and DESSEIN, A.J.

    J. Exp. Med., 170(6), 2065-2080. (IF:15.3)

  34. Characterization of a factor from the U937 cell line that enhances the toxicity of human eosinophils to Schistosomamansonilarvae (1987)
    SILBERSTEIN, D.S., DESSEIN, A.J., ELSAS, P.P., FONTAINE, B. and DAVID, J.R.

    J. Immunol., 138(9), 3042-3050. (IF:7.1)

  35. IgE antibody and resistance to infections. II. Effect of IgE suppression on susceptibility of rat to Schistosoma mansoniinfections (1986)
    KIGONI, E., ELSAS, P.P.X., LENZI, H.L. and DESSEIN, J.A.

    Eur. J. Immunol., 16(6), 589-595. (IF:5)

  36. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187 (1986)
    DESSEIN, A.J., LEE, T.M., ELSAS, P., RAVALESE, J.D., SILBERSTEIN, D., DAVID, J.R., AUSTEN, F.K. and LEWIS, R.A.

    J. Immunol., 136(10), 3829-3838. (IF:7.1)

  37. Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell product on schistosomula of Schistosomamansoni (1985)
    CAUFIELD, J.P., LENZI, H.L., ELSAS, P. and DESSEIN, A.J.

    Americ. J. Pathol., 120(3), 380-390. (IF:6)

  38. Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony stimulating factor(s) (1982)
    DESSEIN, A.J., VADAS, M.A., NICOLA, N. METCALF, D. and DAVID, J.R.

    J. Exp. Med., 156(1), 90-103. (IF:15.3)

  39. IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinellaspiralisinfection (1981)
    DESSEIN, A.J., PARKER, W.L., JAMES, S.L. and DAVID, J.R.

    J. Exp. Med., 153(2), 423-436. (IF:15.3)

  40. Interactions between human eosinophils and schistosomula of Schistosomamansoni. II. The mechanism of irreversible eosinophil adherence (1979)
    BUTTERWORTH, A.E., VADAS, M.A., WASSOM, D.L., DESSEIN, A., HOGAN, M., SHERRY, B., GLEICH, G.J. and DAVID, J.R.

    J. Exp. Med., 150(6), 1456-1471. (IF:15.3)